微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Magnusiomyces capitatus (de Hoog et al.) de Hoog et Smith |
|---|---|
| 商品货号： | TS141925 |
| Deposited As： | Blastoschizomyces capitatus (Diddens et Lodder) Salkin et al. |
| Strain Designations： | 2 |
| Application： | Biomedical Research and Development Material |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | fluconazole-resistant |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar ATCC® Medium 200: YM agar or YM broth ATCC® Medium 325: Malt extract agar (Blakeslees formula) |
| Growth Conditions： | Temperature: 30°C Atmosphere: Typical aerobic |
| Name of Depositor： | D DAntonio |
| Special Collection： | NCRR Contract |
| Isolation： | Urine of 71-year-old man with advanced prostatic cancer, Italy |
| References： | DAntonio D, et al. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J. Clin. Microbiol. 34: 753-755, 1996. PubMed: 8904454 |